Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
When autistic kids grow up, Chapter 4: How did things unfold?
Tempest McDonald sues Vanderbilt University through the Equal Employment Opportunity Commission. Her published NIH paper finds allies.
When autistic kids grow up, Chapter 4: How did things unfold?
Tempest McDonald sues Vanderbilt University through the Equal Employment Opportunity Commission. Her published NIH paper finds allies.
NeuroDev study maps previously unseen genetic variation in Africa
The project is helping to fill critical gaps in the genetic underpinnings of autism and other neurodevelopmental conditions.
NeuroDev study maps previously unseen genetic variation in Africa
The project is helping to fill critical gaps in the genetic underpinnings of autism and other neurodevelopmental conditions.
Cooperating marmosets extend decision-making model of the brain
When a pair of marmosets works together to earn some marshmallow fluff, one of them decides to act only after its brain accumulates enough evidence about what the other is doing, new work shows.
Cooperating marmosets extend decision-making model of the brain
When a pair of marmosets works together to earn some marshmallow fluff, one of them decides to act only after its brain accumulates enough evidence about what the other is doing, new work shows.